Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eterna Therapeutics Inc.

2.45
-0.1800-6.84%
Volume:38.34K
Turnover:97.85K
Market Cap:18.03M
PE:-0.05
High:2.64
Open:2.64
Low:2.45
Close:2.63
Loading ...
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 19, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 14, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Jan 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 20, 2024

Major Issues Report

Form 8-K - Current report
Jan 19, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 23, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report